摘要
目的:观察三仁汤联合莫比可治疗湿热型骨关节炎的疗效及其不良反应。方法:临床收集湿热型骨关节炎患者80例,平均分为治疗组和对照组,分别给予三仁汤+莫比可和盐酸氨基葡萄糖+莫比可口服,治疗时间为1个月。治疗前和治疗后均采用西安大略和麦克马斯特大学骨关节炎指数进行评价,观察两种治疗方法改善骨关节炎症状、疗效及不良反应。结果:两组总疗效比较差异无统计学意义(P>0.05)。治疗后,疼痛、僵硬和功能改善情况组内比较,差异均有统计学意义(P<0.01)。两组之间僵硬和功能改善比较,差异有统计学意义(P<0.05);疼痛改善比较,差异无统计学意义(P>0.05)。不良反应率比较,差异有统计学意义(P<0.05)。结论:治疗组治疗湿热型骨关节炎疗效确切,且不良反应率低。
Objective： To observe effects of the Sanren decoction plus mobic on osteoarthritis of the Shire type and its untoward reaction. Methods： B0 cases were divided into the treatment group and control group. The treatment group was given the Sanren decoction plus mobic; the control group was treated with glucosamine hydrochloride plus mobic, for 1 month. According to WOMAC index, the symptom, efficacy and untoward reaction in group were compared. Results： Compare with before treatment, degree of pain, stiff and functions were improved, with significant differences （P〈0.01）. Compared with groups, there were no significant difference in the total efficiency and degree of pain （P〉0.05）, and significant differences in untoward reaction, degree of stiff and functions （P〈0.05）. Conclusion： The Sanren decoction plus mobic on osteoarthritis of the Shire type is safe and effective, can reduce untoward effects.
出处
《中医临床研究》
2016年第35期92-94,共3页
Clinical Journal Of Chinese Medicine
基金
广东省中医药局项目(20131263)
关键词
骨关节炎
湿热证
WOMAC指数
三仁汤
Osteoarthritis
The Shire type
WOMAC index
The Sanren decoction
